CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 2,228.00
+27.20 (1.24%)
Last updated: Sep 11, 2026, 3:29 PM IST
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 136.76 billion as of September 11, 2026.
Market Cap
136.76B
Enterprise Value
138.12B
Revenue
14.79B
Ranking
n/a
PE Ratio
68.70
Stock Price
2,228.00
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 136.76B, an increase of 55.46%. That is a compound annual growth rate of 81.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 136.76B | 61.46% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.41T |
| Divi's Laboratories | 2.47T |
| Apollo Hospitals Enterprise | 1.27T |
| Lenskart Solutions | 1.19T |
| Syngene International | 152.33B |
| Marksans Pharma | 149.27B |
| Rainbow Children's Medicare | 146.75B |
| NATCO Pharma | 146.04B |